Literature DB >> 18549842

Impact of individual and cumulative coronary risk factors on coronary flow reserve assessed by dobutamine stress echocardiography.

Saeed A L Ahmari1, T Jared Bunch, Karen Modesto, Vicky Stussy, Amy Dichak, James B Seward, Patricia A Pellikka, Krishnaswamy Chandrasekaran.   

Abstract

Traditional cardiovascular risk factors have been shown to cause microvascular dysfunction. Most studies that have evaluated microcirculation rely on invasive measurement tools. We used dobutamine stress echocardiography, a validated method to measure coronary flow velocity (CFV) and coronary flow reserve (CFR), in a previously unstudied population without known significant coronary artery disease to determine the impact of traditional risk factors on CFR. Consecutive patients who had no evidence of regional wall motion abnormalities at rest or during dobutamine stress echocardiography were studied. Left anterior descending artery CFV was measured at baseline and at peak dobutamine stress and CFR was calculated as the ratio of peak stress CFV to baseline CFV. Fifty-nine consecutive patients (28 men) with mean age of 66.8+/-14.5 years were studied. CFR was lower in patients with diabetes mellitus (DM) compared with those without (1.7+/-0.74 vs 2.48+/-0.98, p<0.007), in patients with hypertension compared with those without (2+/-0.8 vs 2.6+/-0.9, p<0.02), and in obese patients compared with nonobese patients (1.6+/-0.5 vs 2+/-0.6, p<0.02). CFR was further impaired in the presence of DM with hypertension, DM with obesity, DM with a wide pulse pressure (>50 mm Hg), and obesity with a wide pulse pressure. In a multivariate model, DM, obesity, and wide pulse pressure were significantly associated with variation in CFR (p<0.0008). In conclusion, CFR was abnormal in patients with DM, hypertension, and obesity. CFR impairment is exaggerated as the number of risk factors increases. Despite a negative dobutamine stress echocardiographic result, aggressive risk factor assessment and control should be implemented in patients with coronary risk factors due to an underlying abnormal CFR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18549842     DOI: 10.1016/j.amjcard.2008.02.055

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

Review 1.  Women with Stable Angina Pectoris and No Obstructive Coronary Artery Disease: Closer to a Diagnosis.

Authors:  Marie Mide Michelsen; Naja Dam Mygind; Daria Frestad; Eva Prescott
Journal:  Eur Cardiol       Date:  2017-08

Review 2.  The cardiovascular effects of GLP-1 receptor agonists.

Authors:  Theodore Okerson; Robert J Chilton
Journal:  Cardiovasc Ther       Date:  2010-12-19       Impact factor: 3.023

3.  Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes.

Authors:  Cecilia Marini; GianPaolo Bezante; Patrizia Gandolfo; Elisa Modonesi; Silvia D Morbelli; Angelo Depascale; Daniela Rollando; Davide Maggi; Manuela Albertelli; Riccardo Armonino; Manrico Balbi; Claudio Brunelli; Renzo Cordera; Gianmario Sambuceti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-03       Impact factor: 9.236

Review 4.  Coronary Microvascular Dysfunction: A Practical Approach to Diagnosis and Management.

Authors:  Daria Frestad Bechsgaard; Eva Prescott
Journal:  Curr Atheroscler Rep       Date:  2021-07-16       Impact factor: 5.113

5.  Functional and Economic Impact of INOCA and Influence of Coronary Microvascular Dysfunction.

Authors:  Christopher L Schumann; Roshin C Mathew; John-Henry L Dean; Yang Yang; Pelbreton C Balfour; Peter W Shaw; Austin A Robinson; Michael Salerno; Christopher M Kramer; Jamieson M Bourque
Journal:  JACC Cardiovasc Imaging       Date:  2021-04-14

6.  Insulin resistance and exercise tolerance in heart failure patients: linkage to coronary flow reserve and peripheral vascular function.

Authors:  Martin Snoer; Tea Monk-Hansen; Rasmus Huan Olsen; Lene Rørholm Pedersen; Lene Simonsen; Hanne Rasmusen; Flemming Dela; Eva Prescott
Journal:  Cardiovasc Diabetol       Date:  2012-08-13       Impact factor: 9.951

7.  The impact of aging and atherosclerotic risk factors on transthoracic coronary flow reserve in subjects with normal coronary angiography.

Authors:  Maurizio Galderisi; Fausto Rigo; Sonia Gherardi; Lauro Cortigiani; Ciro Santoro; Rosa Sicari; Eugenio Picano
Journal:  Cardiovasc Ultrasound       Date:  2012-05-14       Impact factor: 2.062

8.  Coronary microvascular function, insulin sensitivity and body composition in predicting exercise capacity in overweight patients with coronary artery disease.

Authors:  Anders Jürs; Lene Rørholm Pedersen; Rasmus Huan Olsen; Martin Snoer; Elizaveta Chabanova; Steen Bendix Haugaard; Eva Prescott
Journal:  BMC Cardiovasc Disord       Date:  2015-11-27       Impact factor: 2.298

9.  Coronary Microvascular Function and Cardiovascular Risk Factors in Women With Angina Pectoris and No Obstructive Coronary Artery Disease: The iPOWER Study.

Authors:  Naja Dam Mygind; Marie Mide Michelsen; Adam Pena; Daria Frestad; Nynne Dose; Ahmed Aziz; Rebekka Faber; Nis Høst; Ida Gustafsson; Peter Riis Hansen; Henrik Steen Hansen; C Noel Bairey Merz; Jens Kastrup; Eva Prescott
Journal:  J Am Heart Assoc       Date:  2016-03-15       Impact factor: 5.501

Review 10.  Ischemia and No Obstructive Coronary Artery Disease ( INOCA ): What Is the Risk?

Authors:  Romana Herscovici; Tara Sedlak; Janet Wei; Carl J Pepine; Eileen Handberg; C Noel Bairey Merz
Journal:  J Am Heart Assoc       Date:  2018-09-04       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.